Latest: FDA Approves New Biosimilar for Oncology Treatment
Medical Research

STAT+: Pharmalittle: We’re reading about a Trump Jr. company, a GLP-1 health risk, and much more

by STAT News
0 Comments
0 Mins
A company that has Donald Trump Jr. on its board debuted a new service to help pharmaceutical companies launch direct sales platforms
Tags:
STAT News
Author

STAT News

Previous Post
Abridge and Highmark Collaborate on AI-Powered Prior Authorization Solution
Next Post
CDC staff voice fears about agency’s security vulnerabilities in internal calls
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago